olpasiran: Clinical Trials

1 trial of olpasiran, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow olpasiran: new trials by email Literature Review of olpasiran trials Research Report on olpasiran

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study
Olpasiran, Placebo - Cardiovascular Disease
Phase 2CompletedAmgen2812020-07-282026-03-31

Conditions studied

Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Dyslipidemias (1)  ·  Hyperlipidemias (1)

Sponsors

Amgen (1)

Countries

Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  Iceland (1)  ·  Japan (1)  ·  Netherlands (1)  ·  United States (1)

Results publications

PMID 38415744

NIH funding

2019 (1)